Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ImpediMed.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Latest biotech quarterly results are as patchy as the curate’s egg
Health & Biotech
Scott Power: ASX health stocks rise as focus shifts to reporting season
Health & Biotech
Health Check: Control Bionics eyes 20pc revenue growth and ‘near term’ profitability
News
Market Highlights: Fed hints at more rate cuts, gold hits highs, and all eyes on RBA today
Experts
Dr Boreham’s Crucible: The market is there for this innovative lymphoedema detector to win… or lose
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but there’s ‘wind in the sails again’
Health & Biotech
HealthInvest 2024 set to show off latest ASX healthcare innovators
Experts
ScoPo’s Powerplays: ASX health stocks rise despite Friday selloff, and what’s this – a potential cure for ageing?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks hit resistance in first week of FY25
Health & Biotech
ASX medtechs poised to transform healthcare with upcoming catalysts in 2024 – Part 2
Health & Biotech
ScoPo’s Powerplays: Nowhere to hide as ASX health stocks tumble in broader selloff
Director Trades
Skin in the game: Which ASX director is betting on a lithium recovery?
Health & Biotech
ImpediMed’s new leadership team looks to grow the company
Health & Biotech
ScoPo’s Powerplays: Health stocks fall as tight hospital budgets hurt Nanosonics
Health & Biotech
ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint
Health & Biotech
ScoPo’s Powerplays: ASX health stocks up as Cochlear upgrades earnings guidance
